Zhejiang Huahai Pharmaceutical Co Ltd (600521) – Strategy, SWOT and Corporate Finance Report
- Pages: 40
- Published: June 2023
- Report Code: MLPH135710FSA
Zhejiang Huahai Pharmaceutical Co Ltd (600521) – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company
Key Highlights
Zhejiang Huahai Pharmaceutical Co Ltd (Huahai Pharmaceuticals) discovers, carries out the research, production and sale of formulations, active pharmaceutical ingredients (APIs) including ace inhibitors, angiotensin II receptor antagonists, anti-AIDS, anti-depressants, antihistamines, antihypertensives, and antipsychotics, and pharmaceutical intermediates. It also carries out the commercial production of captopril, enalapril and lisinopril. The company has two reportable segments, Main Business and Other Business. In Main Business, the company reports the performance of its Raw Material and Intermediaries; Finished Drugs; Technical Services; Import and Export and Others. The company operates through subsidiaries in the US and China and distributes its products to several countries worldwide. Huahai Pharmaceuticals is headquartered in Zhejiang, China.
Scope
• Detailed information on Zhejiang Huahai Pharmaceutical Co Ltd required for business and competitor intelligence needs
• A study of the major internal and external factors affecting Zhejiang Huahai Pharmaceutical Co Ltd in the form of a SWOT analysis
• An in-depth view of the business model of Zhejiang Huahai Pharmaceutical Co Ltd including a breakdown and examination of key business segments
• News about Zhejiang Huahai Pharmaceutical Co Ltd, such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
• Gain understanding of Zhejiang Huahai Pharmaceutical Co Ltd and the factors that influence its strategies.• Track strategic initiatives of the company and latest corporate news and actions.
• Assess Zhejiang Huahai Pharmaceutical Co Ltd as a prospective partner, vendor or supplier.
• Support sales activities by understanding your customers' businesses better.
• Stay up to date on Zhejiang Huahai Pharmaceutical Co Ltds business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
Nanjing Pharmaceutical Co Ltd
Jiangsu Hengrui Medicine Co Ltd
Health Vision Enterprise Ltd
Harbin Pharmaceutical Group Holding Co Ltd
China Resources Double-Crane Pharmaceutical Co Ltd
Sinochem Hebei Corp
Shanghai Pharmaceuticals Holding Co Ltd
Beijing Pason Pharmaceuticals Inc
China National Accord Medicines Corporation Ltd
Abatra Technology Co Ltd
China National Accord Medicines Corporation Ltd
Nanjing Pharmaceutical Co Ltd
Sinochem Hebei Corp
Health Vision Enterprise Ltd
China Resources Double-Crane Pharmaceutical Co Ltd
Jiangsu Hengrui Medicine Co Ltd
Shanghai Pharmaceuticals Holding Co Ltd
Beijing Pason Pharmaceuticals Inc
Harbin Pharmaceutical Group Holding Co Ltd
Abatra Technology Co Ltd
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple purchases.